Helius Medical Technologies is trading 6.1% down at $2.17 after broad risk-off pressure hit U.S. equities on September 15, 2026.

  • The 10-year Treasury yield reached 5.02%.
  • The Dow, S&P 500, and Nasdaq declined amid elevated oil prices and caution ahead of the Federal Reserve’s September 16 policy decision.
  • No company-specific announcement dated September 15 was identified in the company’s latest releases.